Fareed J - Search Results

1

Jeske WP, Fareed J, Hoppensteadt DA, Lewis B, Walenga JM. Jeske WP, et al. Among authors: fareed j. Expert Rev Hematol. 2010 Oct;3(5):527-39. doi: 10.1586/ehm.10.53. Expert Rev Hematol. 2010. PMID: 21083469 Review.

2

Fondaparinux: a synthetic heparin pentasaccharide as a new antithrombotic agent.

Walenga JM, Jeske WP, Samama MM, Frapaise FX, Bick RL, Fareed J. Walenga JM, et al. Among authors: fareed j. Expert Opin Investig Drugs. 2002 Mar;11(3):397-407. doi: 10.1517/13543784.11.3.397. Expert Opin Investig Drugs. 2002. PMID: 11866668 Review.

3

Prevalence, isotype, and functionality of antiheparin-platelet factor 4 antibodies in patients treated with heparin and clinically suspected for heparin-induced thrombocytopenia. The pathogenic role of IgG.

Untch B, Ahmad S, Jeske WP, Messmore HL, Hoppensteadt DA, Walenga JM, Lietz H, Fareed J. Untch B, et al. Among authors: fareed j. Thromb Res. 2002 Jan 15;105(2):117-23. doi: 10.1016/s0049-3848(02)00004-x. Thromb Res. 2002. PMID: 11958801

4

Molecular and biochemical profiling of a heparin-derived oligosaccharide, C3.

Ma Q, Dudas B, Daud A, Iqbal O, Hoppensteadt D, Jeske W, Cornelli U, Lee J, Lorens S, Mervis R, Hanin I, Capila I, Linhardt R, Fareed J. Ma Q, et al. Among authors: fareed j. Thromb Res. 2002 Feb 15;105(4):303-9. doi: 10.1016/s0049-3848(01)00413-3. Thromb Res. 2002. PMID: 12031824

5

Reference intervals of the dilute tissue thromboplastin inhibition and dilute Russell's viper venom tests revisited.

Gerbutavicius R, Fareed J, Messmore HL Jr, Iqbal O, Hoppensteadt DA, Wehrmacher WH, Demir M, Piccolo P, Ahmad S, Ma Q, Griniute R. Gerbutavicius R, et al. Among authors: fareed j. Clin Appl Thromb Hemost. 2002 Apr;8(2):115-24. doi: 10.1177/107602960200800206. Clin Appl Thromb Hemost. 2002. PMID: 12121051 Free article.

6

Development of a non-human primate sub-clinical model of heparin-induced thrombocytopenia: platelet responses to human anti-heparin-platelet factor 4 antibodies.

Untch B, Ahmad S, Messmore HL, Schultz CL, Ma Q, Hoppensteadt DA, Walenga JM, Fareed J. Untch B, et al. Among authors: fareed j. Thromb Res. 2002 Apr 15;106(2):149-56. doi: 10.1016/s0049-3848(02)00081-6. Thromb Res. 2002. PMID: 12182915

7

Monitoring of argatroban in ARG310 study: potential recommendations for its use in interventional cardiology.

Iqbal O, Ahmad S, Lewis BE, Walenga JM, Rangel Y, Fareed J. Iqbal O, et al. Among authors: fareed j. Clin Appl Thromb Hemost. 2002 Jul;8(3):217-24. doi: 10.1177/107602960200800304. Clin Appl Thromb Hemost. 2002. PMID: 12361198 Free article. Clinical Trial.

8

Preparation and anticoagulant activity of the phosphosulfomannan PI-88.

Yu G, Gunay NS, Linhardt RJ, Toida T, Fareed J, Hoppensteadt DA, Shadid H, Ferro V, Li C, Fewings K, Palermo MC, Podger D. Yu G, et al. Among authors: fareed j. Eur J Med Chem. 2002 Oct;37(10):783-91. doi: 10.1016/s0223-5234(02)01347-8. Eur J Med Chem. 2002. PMID: 12446036

9

Effects of a synthetic factor Xa inhibitor (JTV-803) on various laboratory tests.

Tobu M, Iqbal O, Hoppensteadt DA, Shultz C, Jeske W, Fareed J. Tobu M, et al. Among authors: fareed j. Clin Appl Thromb Hemost. 2002 Oct;8(4):325-36. doi: 10.1177/107602960200800404. Clin Appl Thromb Hemost. 2002. PMID: 12516682 Free article.

10

Differential effects of clivarin and heparin in patients undergoing hip and knee surgery for the generation of anti-heparin-platelet factor 4 antibodies.

Ahmad S, Haas S, Hoppensteadt DA, Lietz H, Reid U, Bender N, Messmore HL, Misselwitz F, Bacher P, Gaikwad BS, Jeske WP, Walenga JM, Fareed J. Ahmad S, et al. Among authors: fareed j. Thromb Res. 2002 Oct 1;108(1):49-55. doi: 10.1016/s0049-3848(02)00397-3. Thromb Res. 2002. PMID: 12586132 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

769 results

Search Page